Literature DB >> 1502013

Effects of valproate on xenobiotic biotransformation in rat liver. In vivo and in vitro experiments.

V Rogiers1, A Callaerts, A Vercruysse, M Akrawi, E Shephard, I Phillips.   

Abstract

Male Wistar rats were in vivo exposed for 2 weeks to 100 micrograms/ml sodium valproate by subcutaneous implantation of osmotic pumps and hepatocytes were isolated. As an in vitro model co-cultures of rat hepatocytes with epithelial cells were daily treated with valproate (25, 50, 100, 200 micrograms/ml) for 2 weeks. In both models the cytochrome P-450 content and the enzymatic activities of 7-ethoxycoumarin O-deethylase, aldrin epoxidase and glutathione S-transferase were determined in valproate-treated hepatocytes, in controls and in phenobarbital-induced cells. It appeared that in both systems the cytochrome P-450 content and the 7-ethoxycoumarin O-deethylase activity increased significantly after valproate treatment. On the other hand, the activities of aldrin epoxidase and glutathione S-transferase decreased. A cDNA probe, encoding rat P450IIB2 was used to determine whether mRNAs encoding the P450IIB subfamily were induced by valproate. It became clear that the inducing effect of valproate was even more pronounced in vitro than in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1502013     DOI: 10.1007/bf01962703

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  23 in total

1.  Effect of the antiepileptic drug sodium valproate on induction of hepatic microsomal P450.

Authors:  N Sapeika; E R Kaplan
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-04

2.  Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.

Authors:  F A de Wolff; A C Peters; G M van Kempen
Journal:  Neuropediatrics       Date:  1982-02       Impact factor: 1.947

3.  7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes.

Authors:  A M Edwards; M L Glistak; C M Lucas; P A Wilson
Journal:  Biochem Pharmacol       Date:  1984-05-01       Impact factor: 5.858

Review 4.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

5.  The inducing and inhibiting effects of sodium valproate in vivo on the biotransformation systems of xenobiotics in isolated rat hepatocytes.

Authors:  V Rogiers; Y Vandenberghe; A Callaerts; W Sonck; V Maes; A Vercruysse
Journal:  Xenobiotica       Date:  1988-06       Impact factor: 1.908

6.  Cloning and sequence analysis of a rat liver cDNA coding for a phenobarbital-inducible microheterogenous cytochrome P-450 variant: regulation of its messenger level by xenobiotics.

Authors:  I R Phillips; E A Shephard; A Ashworth; B R Rabin
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

7.  Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.

Authors:  R G Dickinson; R C Harland; A M Ilias; R M Rodgers; S N Kaufman; R K Lynn; N Gerber
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

8.  Rat liver cytochrome P-450 isozymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes.

Authors:  T Wolff; F P Guengerich
Journal:  Biochem Pharmacol       Date:  1987-08-15       Impact factor: 5.858

9.  Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.

Authors:  H L Bonkowsky; P R Sinclair; S Emery; J F Sinclair
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

10.  Oxidation and glucuronidation of valproic acid in male rats--influence of phenobarbital, 3-methylcholanthrene, beta-naphthoflavone and clofibrate.

Authors:  G Heinemeyer; H Nau; A G Hildebrandt; I Roots
Journal:  Biochem Pharmacol       Date:  1985-01-01       Impact factor: 5.858

View more
  2 in total

1.  2D and 3D QSAR analysis of some valproic acid metabolites and analogues as anticonvulsant agents.

Authors:  T Netzeva; I Doytchinova; R Natcheva
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

2.  Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells.

Authors:  Jana Hřebačková; Jitka Poljaková; Tomáš Eckschlager; Jan Hraběta; Pavel Procházka; Svatopluk Smutný; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2009-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.